PTC制药 PTCT
$65.44 −$0.23 (-0.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $65.39 -0.08%
开盘$65.99
昨收$65.67
当日区间$65.15 – $66.67
成交量899.0K
市值$5.47B
市盈率（TTM）–
股息率–
PTCT 相关新闻
匹配 PTC Therapeutics 或代码 PTCT 的头条新闻，按最新排序。
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137 正面
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120
- TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90
- PTC Therapeutics, Inc.: To Assume Certain Specified Liabilities of Sangamo PTCT
- PTC Therapeutics, Inc.: Upfront Payment of $111 Million, Plus Up to an Additional $100 Million in Contingent Milestone Payments PTCT
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122 正面
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109 正面
- BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96
- Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70 正面
- A Quick Look at Today's Ratings for PTC Therapeutics(PTCT.US), With a Forecast Between $90 to $106
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106
- Morgan Stanley Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $104 正面
- RBC Capital Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Raises Target Price to $85 正面
暂无评论——快来第一个聊聊 PTCT。
登录后参与讨论。